These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 9086428

  • 21. Second trimester maternal serum hCG level in an Asian population: normal reference values by ultrasound dating.
    Jou HJ, Shyu MK, Shih JC, Chang MY, Lim CC, Tzeng CY, Chen SM, Hsieh FJ.
    J Matern Fetal Med; 2000; 9(2):118-21. PubMed ID: 10902826
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Maternal serum triple analyte screening and adverse pregnancy outcome.
    Milunsky A, Nebiolo L.
    Fetal Diagn Ther; 1996; 11(4):249-53. PubMed ID: 8823604
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Adverse outcome of pregnancies with extremely high levels of maternal serum human chorionic gonadotropin.
    Sharony R, Itzhaky D, Amiel A, Hershko A, Grinshpoon Y, Fejgin M.
    Fetal Diagn Ther; 2008; 23(3):233-6. PubMed ID: 18417984
    [Abstract] [Full Text] [Related]

  • 26. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD, McIntosh SF, Halstead AC.
    Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ, Gabert HA, Diket AL, St Amant M, Miller JM.
    J Matern Fetal Med; 1998 Mar; 7(6):304-7. PubMed ID: 9848697
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption.
    Tikkanen M, Hämäläinen E, Nuutila M, Paavonen J, Ylikorkala O, Hiilesmaa V.
    Prenat Diagn; 2007 Mar; 27(3):240-3. PubMed ID: 17238224
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Triploidy identified through second-trimester serum screening.
    Huang T, Alberman E, Wald N, Summers AM.
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Fetal gender impact on multiple-marker screening results.
    Bazzett LB, Yaron Y, O'Brien JE, Critchfield G, Kramer RL, Ayoub M, Johnson MP, Evans MI.
    Am J Med Genet; 1998 Apr 13; 76(5):369-71. PubMed ID: 9556293
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The magnitude of elevated maternal serum human chorionic gonadotropin and pregnancy complications.
    Sharony R, Zipper O, Amichay K, Wiser A, Kidron D, Biron-Shental T, Maymon R.
    J Obstet Gynaecol; 2017 Jul 13; 37(5):576-579. PubMed ID: 28604182
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.